NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Necrotizing Enterocolitis


Return to Library

Free Necrotizing Enterocolitis Articles


Scientists at University of California publish new data on gastroenterology



2009 MAY 18 - (NewsRx.com) -- "Purpose of review Nuclear factor-kappa B (NF-kappa B) is a key transcriptional regulator of innate and adaptive immunity. This review highlights new insights into the functions of NF-kappa B in normal homeostasis and specific disease processes in the intestinal tract," scientists writing in the journal Current Opinion in Gastroenterology report.

"Recent findings Inflammatory bowel disease and experimental intestinal inflammation are characterized by NF-kappa B activation and increased expression of proinflammatory NF-kappa B target genes. Accordingly, NF kappa B inhibition protects against chronic intestinal inflammation and necrotizing enterocolitis in animal models. However, recent findings suggest that NF-kappa B has not only proinflammatory but also tissue-protective functions. Thus, genetic ablation of the regulatory subunit, I kappa B kinase (IKK)gamma, of the central kinase complex required for NF-kappa B activation, IKK, or of both kinase subunits, IKK alpha and IKK beta, in intestinal epithelial cells causes spontaneous murine colitis. Pharmacological inhibition of IKK beta, and loss of IKK beta or NF-kappa B p65 in the epithelium, sensitizes mice to acute inflammatory and injurious challenges. Deficiency in Toll-like receptor 5, a strong activator of NF-kappa B, results in spontaneous colitis and exacerbates mucosal inflammatory responses to Salmonella infection. Conversely, Toll-like receptor 5 stimulation confers radioprotection in the intestine. NF-kappa B has multiple, often opposing functions in the intestine," wrote M.E. Spehlmann and colleagues, University of California.

The researchers concluded: "Antiapoptotic actions of NF-kappa B in intestinal epithelial cells dominate tissue responses to many acute inflammatory and injurious challenges, whereas proinflammatory and cell survival functions of NF-kappa B in macrophages and T cells govern chronic intestinal inflammation."

Spehlmann and colleagues published their study in Current Opinion in Gastroenterology (Nuclear factor-kappa B in Intestinal protection and destruction. Current Opinion in Gastroenterology, 2009;25(2):92-99).

Additional information can be obtained by contacting L. Eckmann, University of California, Dept. of Medical, 9500 Gilman Dr., La Jolla, CA 92093, USA.

The publisher of the journal Current Opinion in Gastroenterology can be contacted at: Lippincott Williams & Wilkins, 530 Walnut St., Philadelphia, PA 19106-3621, USA.

Keywords: United States, La Jolla, Apoptosis, Gastroenterology, Immunology, Inflammation, Inflammatory Bowel Disease, Necrotizing Enterocolitis, University of California.

This article was prepared by Gastroenterology Week editors from staff and other reports. Copyright 2009, Gastroenterology Week via NewsRx.com.

NewsRx NewsRx NewsRx
-----------------------
PR Login